AMA, Omada Health, Intermountain Healthcare Partner to Reduce Incidence of Type 2 Diabetes

News
Article

Chicago, IL; San Francisco, CA; Salt Lake City, UT

— The American Medical Association (AMA), Omada Health, and Intermountain Healthcare today announced an innovative initiative aimed at reducing the alarming number of adults who develop type 2 diabetes. The new collaboration will create a roadmap for large health care organizations across the country to adopt proven online behavior change interventions for at-risk patients, and integrate those programs into provider referral and clinical workflow.

"We're delighted to be partnering with the country's premier physician organization and one of the most innovative health systems in the United States," said Omada Health CEO Sean Duffy. "Intermountain's integration of the Omada program, and AMA's focus on ensuring digital tools work to empower providers will give patients with prediabetes another proven option to meet their care needs. It will also give physicians and their care teams additional treatment options, and actionable data to better understand how to deliver lasting lifestyle change for those in need of it."

Last year, Omada became the first digital health company to publish

peer-revie

wed results demonstrating

that program participants maintained reductions in body weight and average blood sugar levels — critical indicators of diabetes progression – two years after beginning the program.

All three organizations believe evidence-based, technology-enabled care models are key to addressing the more than 86 million Americans who currently have prediabetes. People with prediabetes have higher than normal blood glucose levels, but not high enough yet to be considered type 2 diabetes. Research shows that 15 to 30 percent of people with prediabetes will develop type 2 diabetes within five years unless they lose weight through healthy eating and increased physical activity. Up to 90 percent of people with prediabetes are unaware that they have the condition. Within Intermountain's service area, it's estimated that more than 114,000 people are living with prediabetes.

"This collaboration expands upon the AMA's robust efforts to prevent type 2 diabetes in this country through the scalable adoption of proven innovative tools and resources that can help physicians better manage patients with chronic conditions," said AMA President Andrew W. Gurman, M.D. "With one out of three people at risk of developing type 2 diabetes in their lifetime and at increased risk for serious health problems such as stroke and heart attack, we will continue to do everything we can to significantly decrease the number of American adults who develop the disease."

Combining the AMA's efforts to

raise prediabet

es awareness

nationally, and Intermountain Healthcare's population health strategies to drive better care, this initiative will allow Intermountain physicians and care teams to refer patients to, and monitor their progress through an evidence-based online diabetes prevention program. Access to real-time, actionable data will better position care teams to create specific, personalized patient touch-points to support program completion and success. The collaboration marks the first time that the AMA has worked with a digital healthcare provider to refer high risk patients to an online lifestyle change program.

"Research shows that participation in evidence-based diabetes prevention programs can cut the risk of developing type 2 diabetes by nearly 60 percent," said Dr. Gurman. "Online technology such as Omada's program will help Intermountain physicians and care teams stay connected with their patients as they take proactive steps outside of the clinical setting to prevent type 2 diabetes. By bridging this gap, treatment touch-points with patients over the course of their time in the online program can be more meaningful and impactful, which we believe is a win for both patients and their providers."

Intermountain Healthcare, based in Utah, is recognized as an industry leader in the adoption of innovative preventive care strategies to reduce costs while providing high-quality care.

"The addition of Omada to Intermountain's diabetes prevention program will expand patient access to a CDC-recognized program. We anticipate that access to the Omada program will enhance patient engagement and improve health outcomes," said Elizabeth Joy, M.D., M.P.H., Intermountain's Medical Director for Community Health and Clinical Nutrition.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.